Amarin Corp Plc (AMRN)

[me33]

JL,
I think it's just a poorly worded paragraph. They wanted to emphasize that nothing like RI was done before and went too far. Also, how about Jelis? Or they exclude it because it wasn't a multinational trial? lol
The bottom line, as JT mentioned several times before, V isn't only about lowering trigs. If RI is successful other trigs lowering therapies aren't getting CVD label unless they run successful outcome trials.
I think this is also consistent with the current FDA stand on this.